Index of reports
> Cases with Dehydration (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torisel (Temsirolimus) where reactions include dehydration. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Torisel side effects in 19 year old male
Reported by a physician from United States on 2012-06-25
Patient: 19 year old male, weighing 54.9 kg (120.8 pounds)
Reactions: Dehydration, Photophobia, Haemorrhage Intracranial, Hydrocephalus
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Temozolomide
Dosage: 125 mg/m2, on days 1-5
Administration route: Oral
Indication: Ependymoma Malignant
Start date: 2012-04-23
End date: 2012-04-27
Torisel
Dosage: 35 mg/m2, over 30 minutes on days 1 + 8
Indication: Ependymoma Malignant
Start date: 2012-04-23
End date: 2012-04-23
Irinotecan HCL
Dosage: 90 mg/m2, on days 1-5
Administration route: Oral
Indication: Ependymoma Malignant
Start date: 2012-04-23
End date: 2012-04-24
Possible Torisel side effects in 19 year old male
Reported by a physician from United States on 2012-05-30
Patient: 19 year old male, weighing 54.9 kg (120.8 pounds)
Reactions: Photophobia, Haemorrhage Intracranial, Dehydration, Hydrocephalus
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torisel
Dosage: 35 mg/m2, over 30 minutes on days 1 + 8
Indication: Ependymoma Malignant
Start date: 2012-04-23
End date: 2012-04-23
Temozolomide
Dosage: 125 mg/m2, on days 1-5
Administration route: Oral
Indication: Ependymoma Malignant
Start date: 2012-04-23
End date: 2012-04-27
Irinotecan HCL
Dosage: 90 mg/m2, on days 1-5
Administration route: Oral
Indication: Ependymoma Malignant
Start date: 2012-04-23
End date: 2012-04-24
Other drugs received by patient: Acetaminophen and Oxycodone HCL; Benadryl; Ondansetron; Suprax ^klinge^; Zantac
Possible Torisel side effects in 19 year old male
Reported by a physician from United States on 2012-05-30
Patient: 19 year old male, weighing 54.9 kg (120.8 pounds)
Reactions: Photophobia, Dehydration, Haemorrhage Intracranial, Hydrocephalus
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Irinotecan HCL
Dosage: 90 mg/m2, on days 1-5
Administration route: Oral
Indication: Ependymoma Malignant
Start date: 2012-04-23
End date: 2012-04-24
Temozolomide
Dosage: 125 mg/m2, on days 1-5
Administration route: Oral
Indication: Ependymoma Malignant
Start date: 2012-04-23
End date: 2012-04-27
Torisel
Dosage: 35 mg/m2, over 30 minutes on days 1 + 8
Indication: Ependymoma Malignant
Start date: 2012-04-23
End date: 2012-04-23
Other drugs received by patient: Acetaminophen and Oxycodone HCL; Zantac; Suprax ^klinge^; Benadryl; Ondansetron
Possible Torisel side effects in 71 year old male
Reported by a physician from Germany on 2012-04-24
Patient: 71 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Clostridium Test Positive, Anaemia, Pyrexia, Blood Electrolytes Decreased, Ascites, Escherichia Test Positive, Diarrhoea, Dehydration, Pleural Effusion, Bone Marrow Failure, Thrombocytopenia, Hypertriglyceridaemia, Iatrogenic Infection, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torisel
Dosage: 50 mg, weekly
Start date: 2012-02-02
Torisel
Dosage: 175 mg, weekly
Indication: Mantle Cell Lymphoma
Start date: 2011-10-18
End date: 2011-11-01
Torisel
Dosage: 75 mg, weekly
Start date: 2011-11-08
End date: 2012-01-10
Possible Torisel side effects in 71 year old male
Reported by a physician from Germany on 2012-03-29
Patient: 71 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Clostridium Test Positive, Anaemia, Immunodeficiency, Blood Electrolytes Decreased, Ascites, Escherichia Test Positive, Diarrhoea, Dehydration, Pleural Effusion, Bone Marrow Failure, Thrombocytopenia, Renal Failure Acute, Hypertriglyceridaemia, Iatrogenic Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torisel
Dosage: 75 mg, weekly
Start date: 2011-11-08
End date: 2012-01-10
Torisel
Dosage: 50 mg, weekly
Start date: 2012-02-02
Torisel
Dosage: 175 mg, weekly
Indication: Mantle Cell Lymphoma
Start date: 2011-10-18
End date: 2011-11-01
Possible Torisel side effects in 81 year old male
Reported by a physician from United States on 2012-03-28
Patient: 81 year old male
Reactions: Fatigue, Respiratory Failure, Dehydration, Decreased Appetite
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Sorafenib
Dosage: unk
Administration route: Oral
Indication: Thyroid Cancer
Start date: 2011-09-22
End date: 2011-11-05
Torisel
Dosage: unk
Indication: Thyroid Cancer
Start date: 2011-09-22
End date: 2011-11-02
Possible Torisel side effects in 81 year old male
Reported by a physician from United States on 2011-12-21
Patient: 81 year old male
Reactions: Death, Fatigue, Dehydration, Decreased Appetite
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Torisel
Dosage: unk
Indication: Thyroid Cancer
Start date: 2011-09-22
End date: 2011-11-02
Sorafenib
Dosage: unk
Administration route: Oral
Indication: Thyroid Cancer
Start date: 2011-09-22
End date: 2011-11-07
Possible Torisel side effects in 81 year old male
Reported by a physician from United States on 2011-11-23
Patient: 81 year old male
Reactions: Fatigue, Dehydration, Decreased Appetite
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Torisel
Dosage: unk
Indication: Thyroid Cancer
Start date: 2011-09-22
End date: 2011-11-02
Sorafenib
Dosage: unk
Administration route: Oral
Indication: Thyroid Cancer
Start date: 2011-09-22
End date: 2011-11-07
Possible Torisel side effects in 69 year old male
Reported by a physician from Australia on 2011-11-22
Patient: 69 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Fatigue, Vomiting, Nausea, Diarrhoea, Dehydration, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torisel
|